EMGRAST M 500MCG INJECTION

Emgrast M 500mcg Injection has the active ingredient sargramostim. It is an antineoplastic medication that is part of the class of drugs known as colony-stimulating factors. It is utilized to treat chemotherapy-induced neutropenia and bone Marrow Transplantation. It has also been found to be effective for treating chronic radiation-related syndrome (this occurs when a patient is exposed to excessive levels of radiation for a brief period). This medication is also utilized for treating peripheral progenitor cell transplantation (a medical procedure for replacing damaged or damaged blood cells).
This drug is not advised for those who have a history of hypersensitivity to any of its constituents. It should also not be administered to patients with massive leukemic myeloid blasts or those with a known hypersensitivity to yeast-derived products because this drug is manufactured by yeast cells. In addition, care must be exercised in patients suffering from existing medical conditions, such as chronic heart failure or pulmonary infiltrates kidney insufficiency, because these conditions could be made worse when the treatment is being administered.
This medication has been linked with capillary leak syndrome, a rare condition that causes proteins and fluid to be released from blood vessels into surrounding tissues. Suppose you notice swelling, low blood pressure, or breathing problems. Consult your doctor immediately. It is recommended not to use solutions that contain benzyl Alcohol, such as this injection, that should not be administered to newborns or babies with low birth weight. This medication is not advised during pregnancy because it could cause harm to the baby who is not born. Before starting this treatment, inform your doctor if you are expecting or plan to have a child.